NHS Research Scotland Genetics and Rare Diseases Specialty Group and the Scottish Clinical Genomics Forum Joint Event
Date: 18/11/2026 to 18/11/2026 Venue: V&A, Dundee
The NHS Research Scotland (NRS) Genetics and Rare Diseases Specialty Group and the Scottish Clinical Genomics Forum are hosting an in-person event, free for academic, clinical, government and third-sector colleagues
This event is particularly aimed at members of the Scottish Clinical Genomics community, including Genetic Counsellors and Clinical Geneticists, Trainees/Residents, Nurses and Laboratory Staff and the Scottish genomic research community.
We will be showcasing patient focussed research and development in the field of genomics in Scotland, discussing the changes in genetic testing on both Laboratory and Clinical Genetics Practice across Scotland and how we can collaborate to maintain the best service for our patients. Our speakers and delegates are from within NHS Scotland Services and will be reporting back on experience in all 4 Genetics Services and Laboratories and sharing new ways of working in Clinical Genetics to manage increased patient referrals. We also expect an update from the Scottish Strategic Network for Genomic Medicine.
Venue information
More information on the venue can be found on the V&A Dundee's website.
Programme
This programme is correct at time of publication, and is subject to change.
Novartis and Nanopore Technologies have provided financial sponsorship towards this event. The agenda and organisation of this event were developed independently from sponsors.
|
09:15 - 09:45 |
Registration & trade | |
| Morning Session: NHS Research Scotland (NRS) Genetics and Rare Diseases Specialty Group | ||
|
09:45 - 09:50 |
Introduction and welcome |
Dr Jonathan Berg, University of Dundee |
| Session One: Chaired by Dr Jonathan Berg, University of Dundee | ||
|
09:50 - 10:00 |
Developing the NHS-Academic Partnership |
Dr Jonathan Berg, University of Dundee |
|
10:00 - 10:30 |
Unified Consent Model for Genetic Testing for Scotland: Progress and road map |
Dr Jonathan Berg, University of Dundee; Dr Holly Ennis, Scottish Government |
|
10:30 - 11:00 |
Building a Register for Patients with High Penetrance Cancer Variants |
Dr Helen Hanson, Royal Devon University Healthcare NHS Foundation Trust |
|
11:00 - 11:30 |
Coffee break & trade | |
| Session Two: Chaired by Prof. Zosia Miedzybrodzka, University of Aberdeen | ||
|
11:30 - 12:00 |
Development of ctDNA and Implications for Germline Services |
Prof. Patricia Roxburgh, University of Glasgow |
|
12.00 - 12:30 |
Vaccine trials for Lynch Syndrome (Virtual) |
Prof. David Church, University of Oxford |
|
12.30 - 13:45 |
Lunch, networking & trade | |
|
Afternoon Session: Scottish Clinical Genomics Forum (Closed session) Chaired by Dr Sarah Wedderburn, NHS Greater Glasgow & Clyde |
||
|
13:45 - 14:15 |
CNV Testing in the Scottish Genomics Labs: Current situation and limitations |
Joanne McLean, |
|
|
Prenatal rapid exome update |
David Moore, NHS Lothian |
|
14:15 - 14:25 |
SUDI/SUDIC trio testing |
Dr Jamie Campbell, NHS Lothian |
|
14:25 - 14:35 |
Rationalising Genetic Testing in Scotland: A clinical perspective |
Dr Ruth McGowan, NHS Greater Glasgow & Clyde |
|
14:35 - 14:55 |
Discussion |
Panel |
| 14:55 - 15:10 | Coffee break & trade | |
|
15:10 - 15:20 |
Looking Back, Thinking Ahead: What can clinical genetics service data tell us |
Dr Sarah Wedderburn, |
|
15:10 - 15:20 |
Service Specification |
Dr Catherine McWilliam, NHS Tayside |
|
16:00 - 16:15 |
Establishing and Improving Clinical Pathways for People with Neurofibromatosis Type 1 (NF1) in Lothian |
Dr Sheelagh Harwell, NHS Lothian |
|
16:15 - 16:25 |
Discussion |
Panel |
|
16:25 - 16:30 |
Closing Remarks |
Dr Sarah Wedderburn, NHS Greater Glasgow & Clyde |
